Crescent Biopharma, Inc. Cash Flow Reinvestment Rate
Crescent Biopharma, Inc. cash flow reinvestment rate. Crescent Biopharma, Inc. (CBIO) has a Cash Flow Reinvestment Rate of 0.00x as of September 2015, reinvesting $58.39K (capex $58.39K ) from operating cash flow of $13.56 Million. Explore debt repayment capacity of Crescent Biopharma, Inc. to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Crescent Biopharma, Inc. (2011–2011)
Cash flow reinvestment rate of Crescent Biopharma, Inc. from 2011 to 2011. Historical reinvestment intensity for Crescent Biopharma, Inc. across 1 annual periods. Explore Crescent Biopharma, Inc. (CBIO) reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Crescent Biopharma, Inc. Cash Flow Reinvestment Rate by Year (2011–2011)
Crescent Biopharma, Inc. cash flow reinvestment rate by year from 2011 to 2011. Year-by-year capital reinvestment analysis for Crescent Biopharma, Inc.. For the full cash flow conversion analysis, see cash efficiency ratio of Crescent Biopharma, Inc..
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2011 | 0.01x | $182.44K | $13.85 Million | $182.44K | — |